RUBIUS THERAPEUTICS INC's ticker is and the CUSIP is 78116T953. A total of 3 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $0 | – | 300 | +50.0% | 0.00% | – |
Q4 2022 | $0 | – | 200 | +100.0% | 0.00% | – |
Q3 2022 | $0 | – | 100 | -90.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 1,000 | -88.6% | 0.00% | – |
Q1 2022 | $48,000 | +41.2% | 8,800 | +144.4% | 0.00% | – |
Q4 2021 | $34,000 | -42.4% | 3,600 | +56.5% | 0.00% | – |
Q3 2021 | $59,000 | +5.4% | 2,300 | 0.0% | 0.00% | – |
Q2 2021 | $56,000 | -89.9% | 2,300 | +1000.5% | 0.00% | -100.0% |
Q1 2021 | $553,000 | +3586.7% | 209 | +895.2% | 0.00% | – |
Q4 2020 | $15,000 | – | 21 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 900 | $22,000 | 0.00% |
SIMPLEX TRADING, LLC | 2,300 | $56,000 | 0.00% |